Mednow Investor Update
THE FUTURE
Expansion Roadmap (GM)
How we plan to expand our technology to increase gross margins
and maintain healthy growth in an unpredictable market.
Historic
12%
→ Specialty + chronic medication (GM)
2022 (app launch)
Current
30%
Specialty + chronic medication (GM)
→ Initial user acquisition
Jan 2023
40%
Future Expansion
✓ Specialty + chronic medication (GM)
✓ Initial user acquisition
→ White-labelling for B2B partners to
leverage Mednow technology
→ Non-prescription product sales (via
improved OTC storefront experience)
→ Improved fee structure technology
(for marketing, franchise, and technology
usage fees to third party pharmacies)
→ Unlock purchasing discounts from
increased patient volume (via scaling
B2B partnerships)
May 2023
Breakfast
Fri.. ONE
ITH, JA
08:00 **
31
1547
1000M F
ZINC GLUCONATE
Why Rod To
M
MEDNOW
201
NOW PHARMACY
/23View entire presentation